These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1643355)

  • 1. [Characteristics of autoimmune process in melanoma of the uveal tract].
    Linnik LF; Chabrova LS; Zarobelova ON
    Ross Med Zh; 1992; (3):29-31. PubMed ID: 1643355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
    Nifontova TP
    Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further study of specific immunoreactivity in patients with malignant melanoma of uveal tissue by LAI assay.
    Kalafut F; Cernák A
    Neoplasma; 1982; 29(5):561-6. PubMed ID: 7177245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possibilities of the use of tumor immunity for the diagnosis and prognosis of malignant melanoma of uveal tissue].
    Cernák A; Kalafut F
    Cesk Oftalmol; 1983 May; 39(3):168-71. PubMed ID: 6347408
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary report on monoclonal antibodies against human uveal melanoma.
    Kalafut F; Kusenda J; Novotná L; Cernák A
    Neoplasma; 1987; 34(6):693-701. PubMed ID: 3431609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of the immune status of patients with uveal melanoma during the performance of organ-preserving treatment].
    Maletskiĭ AP; Vit VV; Vanichkin AA
    Oftalmol Zh; 1989; (6):341-6. PubMed ID: 2622598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating melanoma-associated antigens in ocular melanoma.
    Whitmore WG; Witkin SS; Ellsworth RM
    Ann Ophthalmol; 1988 Jun; 20(6):212-7. PubMed ID: 3408088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The morphological forms of malignant uveal melanoma].
    Simionescu C
    Oftalmologia; 1993; 37(1):3-11. PubMed ID: 8507607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypical characteristics, lifestyle, social class and uveal melanoma.
    Stang A; Ahrens W; Anastassiou G; Jöckel KH
    Ophthalmic Epidemiol; 2003 Dec; 10(5):293-302. PubMed ID: 14566630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcomes and prognosis of uveal melanoblastomas following different variants of combined treatment].
    Kotelianskiĭ EO; Zaslavskaia AM
    Oftalmol Zh; 1983; 38(1):9-12. PubMed ID: 6866409
    [No Abstract]   [Full Text] [Related]  

  • 13. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
    Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface antigens of human uveal melanoma identified by monoclonal antibodies.
    Kalafut F; Kusenda J; Novotná L; Cernák A
    Czech Med; 1988; 11(2):73-80. PubMed ID: 3137006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of surface antigens in uveal melanoma using monoclonal antibodies].
    Cernák A; Kalafut F; Kusenda J; Novotná L
    Cesk Oftalmol; 1989 May; 45(3):145-52. PubMed ID: 2743434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is iris melanoma really a nevus?].
    Kremer I; Svetliza E
    Harefuah; 1989 Mar; 116(5):252-4. PubMed ID: 2722076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic aspects in the diagnosis of uveal melanoma].
    Omulecki W
    Klin Oczna; 1986 May; 88(5):175-7. PubMed ID: 3540439
    [No Abstract]   [Full Text] [Related]  

  • 18. [Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase].
    Beutelspacher SC; Serbecic N
    Klin Monbl Augenheilkd; 2008 Aug; 225(8):703-7. PubMed ID: 18712654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the lymphocyte blast transformation reaction as a criterion of prognosis in the outcome of treatment of uveal melanoblastomas].
    Kotelianskiĭ EO
    Oftalmol Zh; 1986; (7):407-9. PubMed ID: 3493458
    [No Abstract]   [Full Text] [Related]  

  • 20. Uveal melanoma: no expression of HLA-G.
    Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.